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ABSTRACT
Background: Vitamin deficiencies are often part of malnutrition,
which predisposes to acute lower respiratory tract infections.
Objective: The objective was to measure the association between
cobalamin and folate status and subsequent respiratory morbidity.
Design: A prospective cohort study was conducted in 2482 children
aged 6–30 mo nested in a zinc supplementation trial. We measured
plasma concentrations of folate, cobalamin, methylmalonic acid,
and total homocysteine (tHcy) and followed the children for 4 mo.
Results: We observed 1176 episodes of acute lower respiratory tract
infections. Children with folate concentrations in the lowest quartile
(interquartile range: 6.4–20.0 nmol/L) had a 44% higher incidence
[adjusted incidence rate ratio (IRR): 1.44; 95% CI: 1.23, 1.70] of
acute lower respiratory tract infections than did children in the other
3 quartiles. For tHcy, the IRR was 1.24 (1.07, 1.40) in a comparison
of those in the highest quartile with those in the other quartiles.
Breastfeeding was associated with high folate concentrations and
protection against subsequent respiratory tract infections. This pro-
tection was significantly and substantially reduced after adjustment
for plasma folate concentrations at baseline. Compared with the
children in the other 3 quartiles, the IRR for being in the lowest
quartile of cobalamin was 1.13 (0.76, 1.03) and for being in the
highest quartile of methylmalonic acid was 1.12 (0.96, 1.31).
Conclusions: Poor folate status appears to be an independent risk
factor for lower respiratory tract infections in young children. This
study also suggests that the protective effect of breastfeeding is
partly mediated by folate provided through breast milk. Am J
Clin Nutr 2007;86:139–44.
KEY WORDS Children, pneumonia, folate, cobalamin, ho-
mocysteine, methylmalonic acid, malnutrition, cohort study, India
INTRODUCTION
In children in developing countries, acute lower respiratory
tract infections are among the most common causes of death,
claiming2 million lives every year (1). Known risk factors are
young age, low birth weight, pollutants, poverty, malnutrition,
zinc deficiency, and lack of breastfeeding (2). Therapeutic or
prophylactic administration of zinc to young children reduces the
risk of acute lower respiratory tract infections and the episode
duration (3–6). Whether deficiencies of other nutrients, such as
folate or vitamin B-12 (cobalamin), are independent risk factors
for lower respiratory tract infections, is not known. The main
sources of cobalamin are animal products, of which poor children
have a low intake (7). It is therefore plausible that many children
of developing countries are cobalamin deficient. Folate defi-
ciency, however, is presumably less prevalent because of the
abundance of folate in breast milk and because of the predomi-
nantly vegetarian diet in many low-income countries, such as in
South Asia (8).
We undertook a prospective cohort study to assess whether
poor folate and poor cobalamin status were risk factors for acute
lower respiratory tract infections in young children.
SUBJECTS AND METHODS
Study population
This study was nested within a zinc supplementation trial in
2482 children aged 6–30 mo. Assessment of the association
between markers of cobalamin and folate status and respiratory
illness were predefined secondary objectives in this project. The
inclusion and exclusion criteria and the effects of zinc adminis-
tration are described elsewhere (3). The ethics committee of the
All India Institute of Medical Sciences in New Delhi approved
the study. Details of the study were given in writing and were also
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read to the parents in the presence of a witness. Signatures or
thumb impressions were obtained on a consent form.
Data collection
A study physician interviewed the caretaker, examined the
child, and collected a venous blood specimen from the child on
enrollment. Fieldworkers visited each child every seventh day
for 4 mo. At each visit, the caretakers were asked about fever,
cough, and other symptoms of disease and whether they had
sought treatment for the child in the previous 7 d. Respiratory
rates were counted twice for 1 min, and the temperature was
recorded. The caretakers were encouraged to bring their children
to the study clinic whenever they were ill. In the field clinic, 2
physicians assessed the child.
Acute lower respiratory tract infection was defined by cough
and fast breathing or lower chest indrawing. Fast breathing was
defined as 2 counts of 50 breaths/min for infants (12 mo of
age) and 40 breaths/min for older children. We defined 2 ep-
isodes to be distinct from each other when they were separated by
14 continuous days without acute lower respiratory tract in-
fection.
Treatment
Acute illness was treated according to the guidelines of the
World Health Organization. Children with acute lower respira-
tory tract infections received co-trimoxazole, which was substi-
tuted with amoxicillin if the child did not respond within 3 d.
Children were sent to the hospital if they had signs or symptoms
that required referral.
Blood collection and biochemical analyses
We collected samples of nonfasting venous blood (5 mL) in
heparinized polypropylene tubes (Sarstedt, Nu¨mbrecht, Ger-
many) between 0900 and 1200. The samples were centrifuged
(447g, 10 min, room temperature), and the plasma was divided
and stored into polypropylene vials (Eppendorf, Hinz, Germany)
at20 °C until analyzed.
All samples were analyzed at the University of Bergen, Ber-
gen, Norway (Section for Pharmacology, Institute of Medicine).
Plasma cobalamin and plasma folate concentrations were
estimated by microbiological assays with the use of a
chloramphenicol-resistant strain of Lactobacillus casei and a
colistin sulfate–resistant strain of Lactobacillus leichmannii, re-
spectively (9, 10). Both assays were adapted to a microtiter plate
format and carried out by a robotic workstation (11). Plasma
methylmalonic acid and total homocysteine (tHcy) were ana-
lyzed with a modified gas chromatography–mass spectrometry
method based on ethylchloroformate derivatizations (12).
Data management and statistical analyses
The data entry forms were designed with FOXPRO for
WINDOWS (Microsoft Corporation, Redmond, WA), with
range and consistency checks incorporated. Double data entry
by 2 data encoders followed by validation was completed within
48 h after the forms were completed in the field. Growth was
assessed by calculating height-for-age and weight-for-age, and
weight-for-height z scores based on the 1978 references with the
use of EPIINFO 6 (13, 14).
Summary measures for continuous variables are reported as
means or medians as appropriate, and categorical variables are
reported as proportions. We used the Mann- Whitney U nonpara-
metric test to compare the plasma concentration of folate, tHcy,
cobalamin, and methylmalonic acid between age and breastfeed-
ing categories. The number of episodes of acute lower respiratory
tract infections was summarized for each child; these summary
measures were used as outcome variables. We used negative
binomial regression to estimate the incidence rate ratio (IRR) for
acute lower respiratory tract infections between categories or
units of the exposure variables. The negative binomial distribu-
tion was used instead of the Poisson distribution because there
was overdispersion in the data. Exposure variables were plasma
concentrations of folate, cobalamin, tHcy, and methylmalonic
acid at the day of inclusion. These variables were included as
dichotomous or continuous variables in generalized linear mod-
els and continuous variables in generalized additive regression
models with the negative binomial distribution family and a
logarithmic link function. We used log (base 2)-transformed
values of the exposure variables when they were right-skewed
and when entered as continuous variables in the regression mod-
els. The exposure variables were also dichotomized into catego-
ries above or below the 25th percentile for folate and cobalamin
and into categories above or below the 75th percentile for tHcy
and methylmalonic acid. We identified predictors for acute lower
respiratory tract infections in a stepwise process. We assessed
whether these and several other variables confounded the asso-
ciation between folate, tHcy, vitamin B-12, or methylmalonic
acid concentrations and respiratory tract infections by adding
them to the multiple model one at a time. These variables were
height-for-age, weight-for-age, and weight-for-length z scores,
age, breastfeeding status, sex, season, zinc supplementation sta-
tus, family type [nuclear or joint (multigenerational)], family
size, income, and years of schooling of the mothers and fathers
(Table 1). Statistical analyses were done with STATA 9.0 sta-
TABLE 1
Variables assessed in the multivariable regression models that measured
the association between plasma folate, cobalamin, homocysteine, or
methylmalonic acid and the subsequent incidence of acute respiratory tract
infections in 2482 Indian children aged 6–30 mo1
Continuous Categorical
Breastfeeding — Yes or no
Age Months Infants: yes or no
Sex — Male or female
Living in multigenerational
families
— Yes or no
Members in the household Number
Years of schooling, mother Years School: yes or no
Years of schooling, father Years School: yes or no
Weight-for-age z score z scores 2 WAZ: yes or no
Weight-for-length z score z scores 2 WHZ: yes or no
Height-for-age z score z scores 2 HAZ: yes or no
Maternal age Years —
Paternal age Years —
Income 1000 Indian rupees —
Time since blood sampling Days —
Season — 3 Categories
Zinc supplementation status — Given: yes or no
1 Interactions assessed: of age with breastfeeding, of age with sex, and
of folate, homocysteine, cobalamin, and methylmalonic acid with breast-
feeding status and age categories.
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tistical software (StataCorp, College Station, TX). We also cat-
egorized the children by whether they had had at least one epi-
sode of pneumonia or not and used this outcome in multivariable
logistic regression analyses including the same exposure vari-
ables as used in the negative binomial regression models. We
used generalized additive models in the statistical software R
version 2.0 (The R Foundation for Statistical Computing) to
describe nonlinear associations between the exposure variables
and acute lower respiratory tract infections after adjustment for
potential confounders (15). To measure the extent of the change
in the effect estimate of breastfeeding after adjustment for plasma
folate concentration, we performed a nonparametric bootstrap
analysis with 1000 replications (16). For each bootstrap replicate
of the data set, we estimated the model parameters both with and
without this adjustment. Bootstrap CIs and P values for the
change in estimates were then computed from the replicated
results.
RESULTS
Demographics and blood indexes
Selected baseline characteristics of the study subjects accord-
ing to breastfeeding status and age categories are shown in
Table 2. The mean (SD) age of the subjects was 15.3  7.5
mo. Fifty-two percent of the subjects were boys, and 69% were
breastfed. The median plasma concentrations of cobalamin, fo-
late, tHcy, and methylmalonic acid were 205 (IQR: 141–299)
pmol/L, 10.7 (6.4–20.0) nmol/L, 10.9 (8.3–14.9) mol/L, and
0.65 (0.37–1.30)mol/L, respectively. The folate concentration
was substantially and significantly lower in children that were
not breastfed than in those who were breastfed (Table 2).
Risk factors for acute lower respiratory tract infections
During a total of 266 537 d of follow-up, there were 848
children who had 1176 episodes of acute lower respiratory tract
infections: 69% of these children had only one episode, 25% had
2 episodes, and 6% had2 episodes. Not being breastfed, young
age, being enrolled in the wet or cool months (June to January)
compared with the months of February to May, and a low length-
for-age z score were all independent risk factors
(Figure 1, Table 3). Socioeconomic factors, however, were not
associated with acute lower respiratory tract infections.
Folate and cobalamin status and acute lower respiratory
tract infections
In the crude analyses, low folate and high tHcy concentrations
were predictors for acute lower respiratory tract infections,
whereas low cobalamin and high methylmalonic acid concen-
trations were not (Table 4). After adjustment for potential con-
founders (listed in Table 1), the associations of folate and tHcy
with respiratory tract infections were maintained, whereas
plasma methylmalonic acid and cobalamin concentrations re-
mained unassociated with respiratory morbidity (Table 4). Fur-
thermore, methylmalonic acid or cobalamin and acute lower
respiratory tract infections were still not associated after inclu-
sion of folate or tHcy concentration in the statistical models.
To avoid overlooking nonlinear associations, we also under-
took multivariable analyses with these markers as smooth terms
in generalized additive models. In these models, with adjustment
for the same variables, both plasma folate (Figure 2) and tHcy
were predictors of acute lower respiratory tract infections. The
inverse association between log IRR and folate concentration
was linear at a folate concentration 20 nmol/L (the lowest 3
TABLE 2
Baseline characteristics of the children in the cohort by breastfeeding status and age1
Variable
Breastfed Not breastfed
6–11 mo 12–30 mo 6–11 mo 12–30 mo
No. of subjects [n (%)] 854 (34.4) 869 (35.0) 152 (6.1) 607 (24.5)
Boys [n (%)] 461 (53.9) 465 (53.5) 79 (52.0) 295 (48.6)
Weight-for-length z score 0.65 0.92 1.52 0.8 1.06 0.9 1.35 0.8
Weight-for-length z score2 [n (%)] 261 (30.6) 559 (64.3) 76 (50.0) 349 (57.5)
Length-for-age z score 1.27 0.9 1.94 1.1 1.64 1.1 1.83 1.2
Length-for-age z score2 [n (%)] 177 (20.7) 392 (45.1) 54 (35.5) 251 (41.4)
Income (in 1000 rupees) 47.2 42.0 44.7 46.8 45.1 32.1 45 32.7
Duration of schooling, mother (y) 5.2 4.5 5.0 4.5 5.4 4.4 5.4 4.7
Duration of schooling, father (y) 8.7 4.0 8.2 4.4 8.5 3.7 8.5 4.1
No. of individuals in household (n) 5.9 2.3 5.8 2.4 6.1 2.7 5.9 2.1
Living in multigenerational families [n (%)] 449 (52.6) 383 (44.0) 89 (58.6) 310 (51.1)
Cobalamin (pmol/L)3,4 184 (120–263)5 172 (124–253) 334 (235–463) 261 (194–348)
Folate (nmol/L)3 20.2 (11.7–34.4) 11.3 (7.4–17.6) 5.3 (3.4–7.7) 6.5 (4.7–9.2)
tHcy (mol/L)3 12.6 (9.2–18.1) 11.3 (8.7–15.2) 10.7 (8.2–13.9) 9.1 (7.4–11.2)
MMA (mol/L)3,6 1.03 (0.54–2.08) 0.74 (0.42–1.36) 0.45 (0.31–0.71) 0.38 (0.26–0.59)
1 tHcy, total homocysteine; MMA, methylmalonic acid.
2 x  SD (all such values).
3 P values were calculated by using the Mann-Whitney U nonparametric test. P values were 0.001 for the differences in cobalamin, folate, tHcy, and
MMA concentrations between breastfeeding categories in infants and toddlers (children aged12 mo) and between infants and toddlers who were breastfed
and those who were not breastfed.
4 P 0.36 for the comparison of cobalamin concentrations between infants and toddlers who were breastfed.
5 Median; intraquartile range in parentheses (all such values).
6 P 0.002 for the comparison of concentrations of MMA between infants and toddlers who were not breastfed.
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quartiles). In contrast, there was a linear and positive association
between the incidence of respiratory tract infections and tHcy
concentrations throughout the whole range of tHcy concentra-
tions. The results from the multivariable generalized additive
models confirmed that there were no associations between base-
line methylmalonic acid or cobalamin and subsequent acute
lower respiratory tract infections.
Children with a folate concentration in the lowest quartile had
a 44% (95% CI: 23%, 70%) higher incidence of respiratory tract
infections than did those with a folate concentration in the highest
3 quartiles (Table 4). The IRR of acute lower respiratory tract
infections was 0.90 (95% CI: 0.84, 0.96) for each doubling [one-
unit increase in the log transformed (base 2) value] of folate
concentration. Thus, the higher the folate concentration, the
lower the incidence.
Those with a tHcy concentration in the highest quartile had a
24% (95% CI: 7%, 40%) (Table 4) higher incidence than did
those with lower concentrations of tHcy. Furthermore, for each
doubling in tHcy concentration, the incidence increased by
22% (95% CI: 10%, 36%). Thus, the higher the tHcy concen-
tration, the higher the incidence of acute lower respiratory
tract infections.
Inclusion of both folate and tHcy in the models did not alter the
estimate of the other compared with when either folate or tHcy
was included in the multivariable negative binomial regression
model. Furthermore, in the multivariable regression models and
in stratified analyses, the associations of acute lower respiratory
tract infections with plasma folate, cobalamin, tHcy, or methyl-
malonic acid were not modified by zinc administration or breast-
feeding status. The protective effect of breastfeeding on respira-
tory tract infections was substantially and significantly reduced
when the folate concentration was added to the regression mod-
els, particularly in infants (Figure 1).
The effect of poor cobalamin status on plasma folate
In this predominant vegetarian population, the plasma folate
concentration may have been high because of cobalamin defi-
ciency, which led to the folate trap phenomenon (17, 18). This
may obscure the assessment of folate status in cobalamin-
deficient subjects. We therefore depicted the association be-
tween plasma cobalamin and plasma folate from continuous gen-
eralized additive models. This analysis showed that the plasma
folate concentration started to increase when the cobalamin con-
centration was 250 pmol/L. We therefore investigated the re-
lation between acute lower respiratory tract infections and folate
in a subgroup with presumably adequate cobalamin status, ie,
plasma cobalamin250 pmol/L. For these children, the adjusted
IRR was 1.53 (95% CI: 1.22, 1.93) in a comparison of the lower
(lower 25%) and upper (upper 75%) 3 quartiles of plasma folate.
Thus, the association between folate and respiratory tract infec-
tions was not significantly different between the subgroups con-
sisting of children with a cobalamin concentration	250 pmol/L
and those with higher cobalamin concentrations (P for interac-
tion 0.2)
DISCUSSION
Our analyses showed a strong and independent association
between low plasma folate concentrations and the risk of acute
lower respiratory tract infections. Children in the lowest quartile
of plasma folate had an almost 50% greater risk than did the other
children. The association between acute lower respiratory tract
infections and folate was not altered by adjustment for other risk
factors for acute lower respiratory tract infections or other po-
tential confounders that we measured.
Children who were not breastfed had a significantly lower
plasma folate concentration than did breastfed children of the
same age. This difference was larger in the lowest age categories.
In fact, breastfed infants had a median folate concentration that
was almost 4 times that of infants who were not breastfed. Our
analyses also showed that children who were breastfed had a
lower incidence of acute lower respiratory tract infections than
did children who were not breastfed. The effect of breastfeeding
on respiratory illness was significantly and substantially reduced
when the folate concentration was included in the regression
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FIGURE 1. Adjusted odds ratios for having 1 episode of an acute
respiratory tract infection between 2482 Indian nonbreastfed and breastfed
infants and children aged 12–30 mo with and without adjustment for plasma
folate concentration at enrollment. To estimate the extent to which the effect
of breastfeeding was altered after adjustment for plasma folate concentration,
we performed a nonparametric bootstrap analysis (16). The estimate for
breastfeeding was attenuated 1.34-fold (95% CI: 1.04, 1.76; P 0.011) and
1.17-fold (95% CI: 1.03, 1.32; P  0.008) in infants and older children,
respectively.
TABLE 3
Predictors of acute lower respiratory tract infection in 2482 Indian
children aged 6–30 mo who were followed for 4 mo1
Variable IRR (95% CI) P
Age
Per month in breastfed, children 0.96 (0.95, 0.98)  0.001
Per month in non-breastfed children 0.99 (0.97, 1.00) 0.015
Interaction of breastfeeding status with age 0.98 (0.96, 0.99) 0.01
Season2
February through May (reference) 1
June through September 1.59 (1.36, 1.87)  0.001
October through January 1.45 (1.22, 1.72)  0.001
Height-for-age
Per z score 0.88 (0.83, 0.93)  0.001
1 IRR, incidence rate ratio (calculated by negative binomial regression
and adjusted for time of blood sampling, sex, zinc supplementation, and
socioeconomic status). The effect of breastfeeding is depicted in Figure 1.
2 P for trend across seasons 0.001.
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models. This indicates that the beneficial effect of breast milk
may be due in part to its folate content.
We found that the incidence of acute lower respiratory tract
infections increased throughout the whole range of tHcy concen-
trations. In adults, the plasma tHcy concentration is a good
marker of folate status, and it increases with declining folate
status (19). Because a low plasma folate concentration was found
to be a strong predictor of respiratory tract infections, we antic-
ipated that the tHcy effect would be attenuated after adjustment
for folate concentration and vice versa. This was, however, not
the case, which suggests that tHcy and folate are independent
predictors of acute lower respiratory tract infections. tHcy is not
a specific marker of folate status (20), and the plasma folate
concentration explained little of the variability of tHcy in our
study (data not shown). Indeed, in newborns and breastfed in-
fants, low plasma cobalamin concentrations are more important
determinants of tHcy than are low folate concentrations (21, 22).
It is therefore surprising that tHcy was associated with acute
lower respiratory tract infections, whereas plasma concentra-
tions of cobalamin and methylmalonic acid were not. Notably,
tHcy increases with activation of the immune system, particu-
larly the TH1 response (23, 24). A high burden of infectious
diseases may therefore cause immune activation and elevated
tHcy, which may explain the association between tHcy at base-
line and subsequent respiratory morbidity.
It is an inherent weakness of cohort studies that they identify
associations rather than causality and that the observed associa-
tions can be due to confounding. We therefore undertook several
multivariable regression analyses with outcomes as dichotomous
(logistic) and count (negative binomial) variables, adjusting for
socioeconomic, anthropometric, and clinical variables. In these
models, the association between folate or tHcy and subsequent
morbidity were not attenuated. However, we cannot rule out that
the observed association is confounded by variables that we did
not measure. For example, children with low folate concentra-
tions could come from homes with poorer indoor air quality,
which is a well-known risk factor for childhood pneumonia (2).
However, plasma folate concentration at recruitment was still
associated with the risk of acute lower respiratory tract infection
after adjustment for family size, income, maternal and paternal
education, and type of housing, which are probably related to
indoor air pollution. Moreover, the plasma folate concentration
could be associated with other nutrients, such as vitamin A, that
might be associated with respiratory tract infections (2). In any
case, our findings need to be verified in clinical trials to have
clinical or public health implications.
The folate trap phenomenon might cause high plasma folate
but low cellular folate concentrations in cobalamin-deficient in-
dividuals (17, 18). However, elevated plasma folate concentra-
tions in children with plasma cobalamin 250 pmol/L would
TABLE 4
Associations between concentrations of the plasma markers of folate and cobalamin status and the incidence of acute lower respiratory tract infections in
Indian children aged 6–30 mo1
Duration of
follow-up
No. of episodes IRR (95% CI)
PTotal Per child-year Unadjusted Adjusted2
d
Folate
Reference (quartiles 2–4) 187 668 759 1.48 1 1
Low (quartile 1) 62 761 359 2.09 1.42 (1.23, 1.63) 1.44 (1.23, 1.70)  0.001
Cobalamin
Reference (quartiles 2–4) 185 309 812 1.60 1 1
Low (quartile 1) 61 403 292 1.74 1.08 (0.93, 1.25) 1.13 (0.76, 1.03) 0.13
Homocysteine
Reference (quartiles 1–3) 186 665 783 1.53 1 1
High (quartile 4) 61 296 316 1.88 1.22 (1.06, 1.42) 1.24 (1.07, 1.40) 0.005
Methylmalonic acid
Reference (quartiles 1–3) 187 140 806 1.57 1
High (quartile 4) 60 702 293 1.76 1.11 (0.96, 1.29) 1.12 (0.96, 1.31) 0.15
1 IRR, incidence rate ratio (calculated by negative binomial regression).
2 Adjusted for age, breastfeeding status, interaction of age with breastfeeding, time of blood sampling, sex, zinc supplementation, nutritional status
(height-for-age z score), socioeconomic status (income, family, size education of parents, and multigenerational or nuclear family), and season.
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FIGURE 2. Association between plasma folate concentration and the
incidence of acute lower respiratory tract infections derived by using gener-
alized additive negative binomial regression models. The vertical lines depict
the 25th, 50th, and 75th percentiles for plasma folate concentration. The
middle curved line depicts the relation between folate concentration and the
incidence rate ratio of acute respiratory tract infection. The outer lines indi-
cate the 95% CIs of the incidence rate ratios. The figure includes the 95%
lowest folate concentrations, and the small lines on the x axis (bottom) show
the distribution of these observations.
FOLATE AND CHILDHOOD RESPIRATORY INFECTIONS 143
 by on August 4, 2010 
w
w
w
.ajcn.org
D
ow
nloaded from
 
then attenuate the folate-respiratory tract infections relation
rather than produce false results. This assumption is in line with
the observation that neither the cobalamin nor the methylmalonic
acid concentration was associated with acute lower respiratory
tract infections. Furthermore, the increased risk of acute lower
respiratory tract infections in children with low folate concen-
trations did not change when we excluded children with poor
cobalamin status from the analysis.
The defense against respiratory tract infections relies on the abil-
ity of the immune cells to proliferate and differentiate and on the
effective renewal of the respiratory epithelial linings. Folates play a
crucial role in DNA and protein synthesis, which suggests that pro-
cesses in which cell proliferation is essential may be impaired by
poor folate status. Indeed, macroscopic disruption of the epithelial
liningoccurswithanti-folate treatment (25),andseveral facetsof the
immune system are affected by folate deficiency (25, 26). The
phagocytic and bactericidal ability of polymorphonuclear leuko-
cytes is poor in individuals with severe folate deficiency and im-
proves with folate replenishment (27). Furthermore, the thymus and
cell-mediated immunity, theblastogenic responseofT lymphocytes
to certain mitogens, and the antibody responses to several antigens
is reduced in folate-deficient individuals (25). These changes to the
immune system caused by folate deficiency may result in an in-
creased susceptibility to infections.
Some antimalarial drugs act on the folate metabolism of the
parasite, and folate administration during sulfadoxine py-
rimethamine prophylaxis has been shown to reduce its efficacy
(28). This needs to be kept in mind if folate is given to populations
in areas where malaria is endemic and sulfadoxine py-
rimethamine is commonly used.
Little attention has been paid to folate deficiency as a public
health problem in children of developing countries. We found
that poor folate status was an independent risk factor for acute
lower respiratory tract infections and that the beneficial effect of
breastfeeding may in part be explained by the high folate con-
centrations in breast milk. Conceivably, folic acid given in ade-
quate amounts may counteract some of the negative conse-
quences faced by children that cannot be breastfed, such as
orphans or children of HIV-infected mothers. These children
may be at increased risk of infections, because of poverty, poor
nutrition, and poor access to health care. Supplementation or
fortification with folic acid may reduce their burden of infection.
This hypothesis, however, should be explored in clinical trials
before any public health measures are taken.
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